A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer

BACKGROUND: To compare the efficiency and toxicity of bevacizumab by intrapleural or intravenous infusion in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer (NSCLC). METHODS: Sensitizing mutation negative NSCLC patients with malignant pleural effusion were ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Keke, Zhang, Zhen, You, Yunhong, Zhuang, Xingjun, Zhang, Chunling, Ji, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938744/
https://www.ncbi.nlm.nih.gov/pubmed/31726490
http://dx.doi.org/10.1111/1759-7714.13238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938744/
https://www.ncbi.nlm.nih.gov/pubmed/31726490
http://dx.doi.org/10.1111/1759-7714.13238

Ejemplares similares